Eli Lilly doubles down on US production with $3.5 billion plant in Pennsylvania
Eli Lilly’s decision to invest more than $3.5 billion in a new Pennsylvania manufacturing facility says...
Read more
Pharmaceuticals
Biotech growth drives AstraZeneca’s new manufacturing move
AstraZeneca’s latest investment in U.S. manufacturing marks a pivotal moment not just for the company, but...
Read more
Johnson & Johnson commits $2 billion to Fujifilm’s North Carolina biopharma hub
A new $2 billion agreement between Johnson & Johnson and Fujifilm Diosynth Biotechnologies is reinforcing the U.S....
Read more
Tariffs trigger a $270B pharma shift back to US production
In 2025, pharmaceutical manufacturers are facing a fundamental disruption. The US government has proposed new tariffs,...
Read more
US Sees Unprecedented $270 Billion in Manufacturing Plans
Fifteen of the world’s leading pharmaceutical companies are collectively investing more than $270 billion into US-based...
Read more